Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b)

The serum levels of TGF-β1, measured by solid-phase ELISA, were determined to be significantly augmented in patients with both relapsing remitting (RR) and secondary chronic progressive (CP) MS compared with sex- and age-matched healthy controls. Moreover, in RR MS patients, the blood levels of the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nicoletti, F, Di Marco, R, Patti, F, Reggio, E, Nicoletti, A, Zaccone, P, Stivala, F, Meroni, P L, Reggio, A
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 1998
Matèries:
Neuroimmunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1905006/
https://ncbi.nlm.nih.gov/pubmed/9697990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2249.1998.00604.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars